Survival of Sarcoma Patients in North West England
Author Information
Author(s): A.L. Hartley, V. Blair, M. Harris, J.M. Birch, S.S. Banerjee, A.J. Freemont, J. McClure, L.J. McWilliam
Primary Institution: Christie Hospital NHS Trust
Hypothesis
How do survival rates of sarcoma patients in North West England compare across different demographics and tumor types?
Conclusion
The overall 5-year survival rate for sarcoma patients was 34%, with significant differences based on age and tumor type.
Supporting Evidence
- Five-year survival for all cases was 34%.
- Survival did not differ significantly between males and females (P = 0.6).
- Patients diagnosed over the median age of 60 years had worse survival (P = 0.03).
- Survival rates varied by tumor site, with bone tumors having a 5-year survival of 44%.
Takeaway
This study looked at how long people with sarcomas lived after being diagnosed, finding that younger patients and those with certain types of tumors lived longer.
Methodology
The study analyzed survival data from sarcoma cases registered in the North Western Regional Cancer Registry between 1982-1984, confirmed by histopathological review.
Potential Biases
Potential bias due to the inclusion of cases diagnosed at post mortem or those not referred for treatment.
Limitations
The study did not include treatment details or grading of tumors, which may affect survival outcomes.
Participant Demographics
The study included 310 sarcoma patients, with a median age of 59.5 years at diagnosis.
Statistical Information
P-Value
0.03
Confidence Interval
29-39
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website